Monoclonal Antibodies for Oncology: Global Markets

Report Highlights

The global market for monoclonal antibodies in oncology is estimated to grow from $76.2 billion in 2022 to more than $138.1 billion by 2027, with a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2022-2027.

Report Includes

• 25 data tables and 24 additional tables
• A brief general outlook of the global monoclonal antibodies for oncology market
• Analyses of the global market trends, with market revenue (sales data) for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
• Highlights of the current and future market potential of monoclonal antibodies for oncology treatment, and areas of focus to forecast this market into various segments and sub-segments
• Evaluation of the actual market size for monoclonal antibodies in oncology treatment, forecasted growth trends, and corresponding market share analysis by type of antibody, application area, and region
• Technology assessment of the key drivers, restraints and opportunities that will shape the market over the next five years (2022 to 2027)
• In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, major types of end-user markets, and COVID-19 implications on the progress of this market
• Review of the patent landscape and new developments in the market for monoclonal antibodies for oncology and associated clinical trials
• Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
• Company profiles of major players within the industry, including AstraZeneca, Bristol-Myers Squibb, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co. Inc. and Pfizer Inc.

Report Scope

The current report provides detailed exposure of global monoclonal antibodies for the oncology market. This report highlights the current and future market potential of monoclonal antibodies for oncology treatment and includes a detailed analysis of the market's drivers, challenges, and opportunities. The report also covers market projections to 2027 and market share for key market players. The report details the market share of monoclonal antibodies for oncology based on type and application. The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios, and recent developments. The report also provides the impact of the COVID-19 pandemic on this market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets (HLC176E)
• Carbon Credits Market: Global Outlook (EGY200A)
• Drugs and Diagnostics for Hematological Disorders: Global Markets (PHM116C)
• Global Flame and Smoke Detectors Markets (MFG092A)
• Biodegradable Polymers: Global Markets and Technologies (PLS025K)